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T Cell Receptor g Gene Regulatory
Sequences Prevent the Function
of a Novel TCRg/pTa Pre±T Cell Receptor
TCR expression and requires extrinsic growth factors,
the most critical being IL-7 and SCF (Rodewald et al.,
1997). TCR gene rearrangements are initiated during
the transition from CD251441 to CD251442 stages. The
latter stage marks a major checkpoint in T cell develop-
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ciently proceed to the CD252CD442 stage (MombaertsBerkeley, California 94720
et al., 1992a; Shinkai et al., 1993; Dudley et al., 1994;²Basel Institute for Immunology
Fehling et al., 1995). The successful TCRb1 cells prolifer-CH-4005 Basel
ate extensively and differentiate into immature ab lin-Switzerland
eage CD41CD81 (double positive [DP]) thymocytes.³Centre d'Immunologic
CD251CD442 TN cells can also differentiate intoInstitut National de la Sante
CD42CD82 (double negative [DN]) gd thymocytes if bothet de la Recherche Medicale
TCRg and TCRd genes are rearranged productively. ThisCentre National de la Recherche Scientifique
process differs in important ways from ab T cell develop-de Marseille-Luminy
ment. First, TCRg and d genes undergo rearrangement13288 Marseille Cedex 9
more or less coordinately, whereas b genes are re-France
arranged considerably before the a genes (Godfrey et
al., 1994; Petrie et al., 1995; Wilson et al., 1996). Indeed,
there is no evidence to date to suggest that the TCRgSummary
or -d chain functions separately with putative surrogate
chains (Passoni et al., 1997; Kang et al., 1998). Second,Expression of a TCRg transgene in RAG-12/2 mice
unlike ab lineage cells, gd lineage thymocytes do notresulted in the development of a limited number of
appear to undergo extensive proliferation during devel-CD41CD81 (DP) thymocytes. In vivo treatments with
opment and constitute only approximately 1% of thymo-anti-TCRg antibody enhanced the number of DP thy-
cytes. The less extensive cell expansion suggests thatmocytes, demonstrating that TCRg chains were ex-
gd receptor expression by these cells imparts a distinctpressed on the cell surface in the absence of d, a, or
signal, in quality or quantity, compared to the signal
b chains. Mutations in pTa or CD3e genes abolished
imparted by the pre-TCR in ab lineage cells.
transgene-induced DP cell development, indicating
The TCRb-dependent transition of CD251442 TN thy-
that TCRg can associate with pTa and CD3 to form a
mocytes to later stages of T cell development requires
novel pre-TCR. With a transgene containing additional
association of the TCRb chain with the surrogate a chain
regulatory sequences, TCRg expression was down- (pTa) and the CD3 signaling molecules. Mice with de-
regulated in DP cells, and little DP cell development fects in expression of the functional pre-TCR complex
occurred. Thus, the function of the endogenous TCRg/ are characterized by an arrest in development of most
pTa is limited by the transcriptional down-regulation or all differentiating thymocytes at the CD251442 TN
of TCRg genes that normally accompanies DP cell stage; mutations in the RAG (Mombaerts et al., 1992b;
development. Shinkai et al., 1992) and scid (Rothenberg et al., 1993)
genes, which are necessary for TCR gene rearrange-
Introduction ment, the TCRb gene (Mombaerts et al., 1992a), the pTa
gene (Fehling et al., 1995), and the CD3e gene (Malissen
Normal development of ab and gd T lymphocytes re- et al.,1995) result ina severe T cell developmental block.
quires a properly coordinated generation and expres- In RAG2/2 mice, for example, the developmental arrest
sion of functional TCR chains. Somatic recombination results in an approximately 100-fold reduction in thymus
of TCRg, d, b, and a genes occurs early in Tcell differenti- cellularity, which can be reversed by expression of a
ation in the thymus. If a thymic precursor produces func- productively rearranged TCRb chain transgene in the
tional TCRg and d chains, it can develop into a gd cell; mice (Shinkai et al., 1993). These results and others
conversely, generation of productive TCRb gene re- (Dudley et al., 1994) have clearly established that the
arrangements permits a precursor to differentiate along pre-TCR complex is necessary for normal differentiation
the ab lineage. The immature CD42CD82CD32 (triple of precursor cells into ab lineage DP thymocytes.
negative, TN) thymocyte subset that contains precur- The requirement for the pre-TCR in the development
sors for T cells can be ordered into developmental inter- of DP cells can be overcome by several experimental
mediates by the expression of CD25 and CD44 mole- manipulations that bypass or mimic pre-TCR signaling.
cules in the following maturational sequence: CD252441 Injection of MAbs against the CD3e chain can stimulate
to CD251441 to CD251442 to CD252442 (Godfrey et al., DP cell development in RAG2/2 (Jacobs et al., 1994;
1993). Maturation to the CD251 stage is independent of Shinkai and Alt, 1994) or pTa2/2 mice (Fehling et al.,
1997), as can the expression of activated Lck (Mom-
baerts et al., 1994), a signal downstream of the TCR, and§To whom correspondence should be addressed (e-mail: raulet
@uclink4.berkeley.edu). activated Ras (Swat et al., 1996), a signal downstream of
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various receptor/tyrosine kinases, including Lck. Fur-
thermore, expression of activated Notch protein in
TCRb2/2 mice enhances the development of DP thymo-
cytes (Washburn et al., 1997). All of these manipulations
result in the production of nearly normal numbers of
DP thymocytes. Other inductive signals only partially
restore DP cell numbers, such as sublethal irradiation
of RAG2/2 (Zuniga-Pflucker et al., 1994; Guidos et al.,
1995) and scid (Danska et al., 1994) mice, expression
of a CD4 transgene (Norment et al., 1997), mutation of
the p53 suppressor gene (Jiang et al., 1996), or overex-
pression of the antiapoptotic bcl-2 transgene (Linette
et al., 1994) in RAG2/2 mice.
TCRgd expression also impacts ab T cell develop-
ment. ab lineage cells, including DP cells and mature
ab T cells, exhibit a selective depletion of productive
TCRg and -d gene rearrangements (Dudley et al., 1995;
Kang et al., 1995; Livak et al., 1995). Additional trans-
genic studies indicate that coexpression of the g and d
TCR chains in a progenitor cell, as a gd TCR, usually
prevents the cell from contributing to the DP cell popula-
tion (Dent et al., 1990; Livak et al., 1997; Kang et al.,
1998). These findings suggest that differential signaling
from the gd receptor and the TCRb/preTa receptor result
in different developmental outcomes for developing T
cells, but the underlying mechanisms are not well under-
stood. Importantly, it is unclear whether some of the
differential signaling arises because only TCRb can pair
with the pTa subunit, or whether the pre-TCR function
is regulated by a lineage-restricted expression of the
components of the pre-TCR. Here, we have investigated
this issue by generating mice that express a TCRg chain,
but not TCRb, TCRd, or TCRa chain, in developing T
cells. The results indicate that TCRg chain can in fact Figure 1. Generation of CD25intCD41CD81 Thymocytes by the TCRg
Transgene Expression in RAG2/2 Miceinteract with pTa and support limited DP cell develop-
ment. However, we demonstrate that the repression of (A) Presence of DP thymocytes in TCRg transgenic RAG-12/2 mice.
Littermates (5 weeks old) for B6 transgenic line 2 (13 copies of theTCRg gene transcription that normally occurs in ab lin-
transgene) that had been backcrossed twice to B6 RAG-12/2 miceeage T cells (Garman et al., 1986; Ishida et al., 1990)
were stained with MAbs specific for CD4, CD8, CD25, and CD44prevents significant development of DP cells by this
and analyzed by four-color flow cytometry. Representative profiles
pathway. These results have significant implications for from the same analysis of another transgenic RAG2/2 line (three
the developmental processes that regulate the gd/ab copies of the transgene) are also shown. The numbers in the lower
cell fate decision. parentheses represent the total number of thymocytes from each
mouse. The numbers in the quadrants represent the percentage of
cells in the particular quadrant.
(B) Proportions of BrdU-labeled DP and DN thymocytes are similarResults
among RAG2/2, g transgenic RAG2/2, and normal littermate mice.
BrdU was administered over a 24 hr period, and the cells were
TCRg Transgene Expression in RAG-12/2 Mice analyzed after staining with MAbs specific for CD4, CD8, CD25, and
Leads to DP Thymocyte Development BrdU.
To generate mice in which TCRg is expressed in devel-
oping T cells, but TCRb, d, and a are not, we generated showed a lower proportion (range: 15%±31%) of DP
RAG-12/2 mice that harbor a rearranged TCRg trans- thymocytes (Figure 1A). As expected, development of
gene. The TCRg transgene (Vg2-Jg1-Cg1) was derived mature single positive T cells was blocked in the g
originally from the G8 gd T cell that has been described transgenic RAG2/2 mice. Although TCRg transgene ex-
in detail previously (Dent et al., 1990). We were surprised pression induced significant differentiation of precursor
to observe that expression of the TCRg transgene alone cells to DP thymocytes in RAG-12/2 mice, the average
in RAG-12/2 mice led to the generation of appreciable total absolute thymocyte number in the transgenic
numbers of DP thymocytes (Figure 1A), whereas DP RAG2/2 mice (1.8 3 106, n 5 15) was not greatly elevated
cell development was never observed in nontransgenic from that of nontransgenic littermates (1.3 3 106, n 5
RAG-12/2 mice. In transgenic RAG-12/2 mice generated 10) and was much lower than the number of thymocytes
with a high copy transgene founder line (13 copies), the in normal mice or TCRb transgenic RAG2/2 mice (ap-
proportion of DP thymocytes ranged from 29% to 52% proximately 108). Therefore, compared to the TCRb
of total thymocytes, whereas transgenic RAG-12/2 mice chain, the transgenic TCRg chain allows only limited
development and/or proliferation of DP cells.with a lower transgene copy number (three copies)
A Pre-TCR Containing TCRg Chains
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Figure 2. Increased Thymus Cellularity and
DP Thymocyte Number in Mice Injected with
Anti-Vg2 Transgenic TCR MAb
(A) Total thymocyte numbers in trangenic
RAG2/2 mice injected with anti-transgenic
Vg2 TCR MAb (UC3) are compared to those
injected with control MAbs (anti-Vg3 TCR or
anti-hamster IgG alone) or saline. Also shown
are thymocyte cell numbers in nontransgenic
RAG2/2 littermates injected with anti-trans-
genic Vg2 TCR MAb. Bars indicate average
cell numbers in each group (PBS injected:
1.2 3 106; anti-hIgG injected: 1.5 x 106; anti-
Vg3 TCR MAb injected: 1.2 3 106; anti-Vg2
TCR MAb injected: 15.9 3 106; anti-Vg2 TCR
MAb injected into nontransgenic RAG2/2
mice: 1.4 3 106).
(B) Increased proportion of CD252 DP thymo-
cytes in transgenic RAG2/2 mice injectedwith
anti-transgenic Vg2 TCR MAb. Thymocytes
isolated 5 days after the Ab or saline injection
were stained with MAbs specific for CD4,
CD8, CD25, and CD44. Representative profiles from four-color flow cytometric analysis are shown. The compensation settings required for
the four-color analysis force many of the events to become crowded on the axes in some of the plots. The numbers in the parentheses refer
to the total number of thymocytes from the mice analyzed.
Measurement of thymidine analog BrdU incorporation Transgenic TCRg Chain Is Expressed on
the Surface of RAG-12/2 Thymocytesshowed that the DP thymocytes generated by TCRg
To examine how the transgenic TCRg chain functionstransgene expression were labeled to a similar propor-
in RAG-12/2 mice, we first determined whether it wastion (average 6 SEM 5 31.4 6 1.5%, n 5 5) as normal
expressed on the cell surface. In flow cytometric analy-DP thymocytes (28.2 6 0.6%, n 5 4) during a continuous
sis, we could not reliably detect the transgenic Vg2 TCR24 hr BrdU administration (Figure 1B). The proportions
on the cell surface, suggesting that the cell surface ex-of total DN cells and of the CD251 DN subsets that had
pression, if any, was very low (data not shown). There-incorporated BrdU were also virtually indistinguishable
fore, an in vivo functional assay was used to assess cellamong the normal, transgenic RAG-12/2 and nontrans-
surface expression of the g chain. Based on the earliergenic RAG-12/2 littermate animals. The similar labeling
findings that MAbs specific for the CD3e chain can in-patterns suggest that the lower number of DP cells in
duce the generation and expansion of DP thymocytesg transgenic RAG-12/2 mice as compared to wild-type
(Jacobs et al., 1994; Shinkai and Alt, 1994; data notmice may reflect a lower number of cell divisions and/
shown), we determined whether MAb specific for theor a reduced differentiation rate of these cells rather
transgenic g chain could induce the generation of DPthan a dramatically increased rate of cell death. Consis-
cells. Injection of anti-Vg2 MAb led to an 11-fold averagetent with this possibility, sorted DP cells from the
increase in thymocyte number in RAG-12/2 g transgenictransgenic RAG-12/2 mice survived as well as normal
mice 5 days after injection but had no effect in non-DP cells when maintained in culture overnight (data not
transgenic RAG-12/2 mice (Figure 2A). This increase wasshown).
largely accounted for by the enlargement of DP popula-The DP thymocytes generated by the TCRg transgene
tion in the transgenic mice, in terms of increased propor-expression were HSAhi, CD5lo, fasnull (data not shown), in
tion of the DP cells (55%±85% of total, Figure 2B) and
contrast to normal DP thymocytes, which are HSAhi,
an average 16-fold increase in the numbers of DP cells.
CD5int, fashi. Moreover, the DP thymocyteswere predom-
Furthermore, the Ab injection resulted in increased ex-
inantly CD25int, clearly distinguishing them from normal pression of the CD5 and fas antigens on DP cells (data
CD252 DP thymocytes that arise through the signals not shown) and down-regulation of CD25 (Figure 2B).
delivered by the TCRb/pTa complex (Figure 1A). It is These phenotypic alterations were not seen in mice in-
possible that CD25 expression is retained on these cells jected with saline alone (Figures 2A and 2B) or with an
from the CD251 TN stage of thymocyte differentiation, isotype-matched control MAb directed against another
perhaps because the DP thymocytes from TCRg trans- Vg TCR chain (Figure 2A; data not shown). These results
genic RAG-12/2 mice undergo less cell division than strongly suggested that the TCRg chain was expressed
normal DP thymocytes. Consistent with this possibility, on the surface of RAG-12/2 thymocytes at functionally
there were few CD252442 TN intermediate stage thymo- relevant levels, and that signals resulting from the cross-
cytes in the transgenic RAG-12/2 mice (Figure 1A). A linking of this receptor mimic the TCRb/pTa pre-TCR
similar reduction or absence of CD252442 TN thymo- signals that permit DP cell development.
cytes has been previously reported in DP thymocyte
development from precursor cells in CD3z2/2 (Crompton Evidence for an Alternative CD32Associated
et al., 1994), TCRb2/2 (Mombaerts et al., 1992a; Godfrey Pre-TCR Complex Composed
et al., 1994), and pTa2/2 (Fehling et al., 1995; Fehling et of TCRg and pTa
al., 1997) mice. All of these mouse strains also harbor To assess the role of the CD3 complex in mediating the
effects of the transgene in RAG-12/2 mice, transgenicCD25int DP cells.
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analysis has shown that RAG2/2pTa2/2 thymocytes are
identical in phenotype to RAG2/2 thymocytes, with all
thymocytes being arrested in development at the CD251
442 TN stage (Fehling et al., 1997).
No DP thymocytes developed in TCRg transgenic
pTa2/2RAG2/2 mice, demonstrating that DP cell devel-
opment induced by the TCRg transgene in RAG2/2 mice
was strictly dependent on expression of the pTa chain
(Figure 4). The data unequivocably demonstrate the re-
quirement of both pTa and CD3 signaling molecules for
the TCRg-induced development of DP thymocytes from
precursor cells. Since the RAG2/2 mice cannot express
any other TCR chains, the results strongly suggest that
Figure 3. CD3e Chain Is Necessary for TCRg Chain±Mediated DP TCRg and pTa form a novel CD32associated functional
Thymocyte Generation pre-TCR complex. Thus, pTa can potentially function
Thymocytes of TCRg transgenic CD3e2/2RAG-12/2 and CD3e1/2 with two distinct types of TCR chain, b and g, that define
RAG2/2 littermate mice were stained with anti-CD4 and CD8 MAbs. two mutually exclusive T cell subsets. Unlike the pre-
Three other TCRg transgenic CD3e2/2RAG-12/2 mice showed identi-
TCR containing the TCRb chain, the pre-TCR containingcal results.
the TCRg chain induces DP cell development only ineffi-
ciently, unless the receptor is cross-linked with antire-
RAG-12/2 mice were crossed to CD3e2/2 mice (Malissen ceptor Abs.
et al., 1995) to generate TCRg transgenic RAG-12/2
CD32/2 mice. Expression of the transgene in the double
deficient mice did not stimulate development of DP thy- Endogenous TCRg Chain Mediates
DN to DP Transition Inefficientlymocytes, nordid italter the phenotype of DN thymocytes
compared to those in CD3e2/2 mice (Figure 3; data not Although the transgenic TCRg chain can form an alter-
nate pre-TCR to allow precursor cells to differentiateshown). Injection of MAb specific for the transgenic Vg2
TCR chain into transgenic RAG-12/2 CD32/2 mice also into DP thymocytes in RAG2/2 mice, the question re-
mained whether the endogenous TCRg chain can func-had no effect (data not shown). Hence, TCRg-mediated
generation and expansion of DP thymocytes absolutely tion in the same manner. To address this issue, we
first analyzed the extent of DP thymocyte generation inrequires the CD3 signaling complex.
The observation that TCRg signaling in RAG2/2 mice TCRb2/2d2/2 mice, in which only TCRg and a genes
can potentially produce functional TCR chains. In adult,depends on the CD3 complex suggested that g chains
may associate with a partner chain other than TCRd to newborn (data not shown), and fetal (Figure 5A) double
deficient mice, but not in RAG-12/2 mice, very smallform a novel pre-TCR complex. To test the role of the
pTa chain in DP thymocyte generation mediated by numbers of DP thymocytes were detected (range: 0.3%
to 1.2% of total thymocytes, n57). While previous stud-the TCRg chain, TCRg transgenic RAG2/2 mice were
crossed to pTa2/2 mice (Fehling et al., 1995). Previous ies of b2/2d2/2 mice emphasized the absence of DP
Figure 4. The Generation of DP Thymocytes
in TCRg Transgenic Mice Is Completely De-
pendent on pTa
(Upper) CD4/8 staining pattern of thymocytes
from mice with the indicated genotype (WT,
wild-type C57BL/6; RAG2/2, RAG-1-deficient;
RAG2/2 3 TCRg-TG, RAG-1-deficient, G8
TCRg transgenic expressing [pTa1] or lacking
[pTa2/2] the pTa gene). Thymocytes were
stained with Abs specific for CD4 and CD8.
Before sample acquisition, propium iodide
was added to efficiently exclude dead cells.
The numbers on top of each profile refer to
the total number of thymocytes from the par-
ticular mouse analyzed.
(Lower) CD25/44 staining pattern of TN thy-
mocytes was examined by gating out thymo-
cytes positive for CD3, CD4, CD8, CD19, GR-1,
and MAC-1 (all FITC-conjugated). CD25-bio-
tin/strepavidin-APC and CD44-PE staining
pattern was then analyzed in FITC-negative/
low cells. The data presented are representa-
tive of four independent experiments and
confirm that the DP thymocyte generation in
TCRg transgenic RAG2/2pTa1 mice occurs
without significant down-modulation of CD25
at the TN stage.
A Pre-TCR Containing TCRg Chains
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Figure 6. Expression of the TCRgSi Transgene Is Down-Modulated
in ab Lineage DP Thymocytes in Normal Mice
RNAse protection assay using G8 VDJ junction sequence-specific
riboprobe shows that TCRgSi transgene expression (gSiTg1), likeFigure 5. DP Thymocytes Are Generated Inefficiently in TCRb2/2d2/2
endogenous g gene expression, is significantly reduced in sorted DPand in gSi Transgenic Mice
thymocytes compared to that of sorted DN and TCRgd1 thymocytes.(A) Representative CD4/CD8 profiles of fetal and 5-week-old adult
The estimated extent of reduction in rearranged Vg2 gene expres-thymocytes of TCRb2/2d2/2 mice compared to RAG-12/2 mice that
sion from DN to DP thymocytes as determined by the densitometriclack DP thymocytes.
analysis is shown at the bottom. Levels of TCRg gene expression(B) Expression of TCRgSi transgene in RAG2/2 mice also leads to
in sorted DN and DP thymocytes from nontransgenic B6 mice (Tg2)the development of very few DP thymocytes. Thymocytes from RAG-
and TCRg transgenic mice (gTg1), where the g transgene expression12/2 littermates from the mating of gSi transgenic RAG1/2 and non-
is maintained in DP thymocytes, are shown for comparison. Similartransgenic RAG2/2 mice were stained with anti-CD4 and CD8 MAbs.
results were obtained with another TCRgSi founder line. ArrowsAnother independently derived gSi transgenic RAG2/2 line showed
indicate the identities of protected RNA fragments, including g actinidentical results.
mRNA used here as a loading control; endo Vg2 refers to protected
endogenous rearranged Vg2 gene with distinct VDJ junction se-
quences. Undigested probes (gA, g actin; v2, G8 VDJ junction) arethymocytes in these mice, small numbers of DP cellscan
shown on the right.
also be seen in previously published data (Mombaerts et
al., 1992a; Passoni et al., 1997). Like the DP thymocytes
in TCRg transgenic RAG-12/2 thymocytes, the DP thy- (Figure 7), suggesting that the TCRgSi transgene func-
tions similarly to the original TCRg transgene in promot-mocytes in TCRb2/2d2/2 mice were also CD25int (data
not shown). Hence, the endogenous TCRg gene may be ing enhanced gd cell development. The increased frac-
tion of Vg21 cells among DN cells in the transgenic micecapable of inducing some DP cell generation, but it may
do so much less efficiently than the TCRg transgene. was reflected by a comparable increase in the level
of Vg2 transcripts in transgenic DN cells compared toOne possible explanation for the poor functional activ-
ity of the endogenous g gene versus the TCRg transgene normal DN cells. Therefore, it is likely that the bulk of
the increased transcript levels in the transgenic miceis that the endogenous TCRg genes are transcriptionally
repressed in DP cells and other resting ab lineage cells resulted from a larger fraction of DN cells expressing
rearranged Vg2 genes, as opposed to a large increase(Garman et al., 1986; Ishida et al., 1990), whereas the
transgene is constitutively expressed in these cells (Fig- in the level of g transcripts in each DN cell. Consistent
with this conclusion, the levels of cell surface gd recep-ure 6; data not shown). To assess the significance of g
gene repression in pre-TCR-mediated generation of DP tors in the transgenic mice were comparable to those
in normal mice (Figure 7).cells, we employed another set of TCRg transgenic mice
in which the TCRg transgene is regulated similarly to TCRgSi transgenic mice were crossed to RAG-12/2
mice to generate TCRgSi1RAG-12/2 mice. Unlike thethe endogenous TCRg (Vg2-Jg1Cg1) gene. The alternate
form of the TCRg transgene (gSi) contained an additional original TCRg transgene, the TCRgSi transgene in RAG-
12/2 mice promoted the development of only very small39 flanking genomic sequence (approximately 10 kb in
size) downstream of the Cg1 enhancer. Expression of numbers of DP cells (0.4% to 1% of total thymocytes,
n 5 5), indistinguishable from the numbers observed inthe TCRgSi transgene was suppressed 12- to 15-fold in
normal ab lineage DP thymocytes when compared to TCRb2/2d2/2 double deficient mice (Figure 5B). Similar
to the DP thymocytes in TCRg transgenic RAG2/2 andthe transgene-specific RNA level in DN thymocytes (Fig-
ure 6). In contrast, the transgene expression was not in TCRb2/2d2/2 mice, the few DP thymocytes in TCRgSi
transgenic mice were also CD25int (data not shown).down-regulated in TCRgd1 thymocytes. Expression of
the transgene in normal mice increased the absolute Identical results were obtained with an additional
TCRgSi transgenic line, which also expressed thenumbers and proportions of gd thymocytes to the same
extent as did the ectopically expressed TCRg transgene transgene at relatively high levels in DN thymocytes.
Immunity
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Figure 7. Both g and gSi Transgene Expres-
sion in Normal Mice Lead to an Increased
TCRgd1 Thymocyte Development
Gated DN thymocytes from TCRg or TCRgSi
transgenic mice were stained with MAbs spe-
cific for Vg2 TCR and pan-TCRgd. Both types
of transgenic mice show a greater than 2-fold
increase in the proportion of gd thymocytes
when compared to nontransgenic littermates.
Most of gd thymocytes from the transgenic
mice express Vg2 TCR.
The lower capacity of the TCRgSi transgene to induce signals through the TCRb/pTa instead of the TCRg/pTa
complex in developing precursor cells. Our results high-DP cell development cannot be attributed to generally
lower transgene expression in DN cells, because trans- light the role of transcriptional repression of g expres-
sion in reinforcing the lineage decision made by devel-gene RNA levels in DN cells of TCRgSi transgenic mice
were similar to the levels in the lower copy TCRg oping progenitor cells.
The coordinate requirement for TCRg, pTa, and CD3etransgenic line in which much higher numbers of DP
thymocytes were generated (Figures 1A and 6; data not for DP cell development in the absence of other TCR
chains, coupled with the evidence that TCRg is ex-shown). The data support the conclusion that the failure
of the TCRgSi transgene to support significant DP cell pressed on the cell surface in these mice, strongly sug-
gests that the three proteins are physically associated.development is due to the suppression of TCRgSi
transgene expression that occurs in ab lineage T cells. This conclusion is supported by the observation that
anti-Vg2 Abs, like anti-CD3e Abs, could stimulate en-One other possible explanation for the smaller number
of DP thymocytes in TCRgSi RAG-12/2 transgenic mice hanced DP cell generation in the g transgenic RAG-12/2
mice. Direct biochemical demonstration of the alterna-is that the suppression of TCR expression in DP thymo-
cytes results in the rapid disappearance of these cells. tive pre-TCR is hampered by the extremely low levels
of pre-TCR expression, which makes detection of evenThis possibility appears unlikely, however, since DP
cells persisted for at least a month in other scenarios the conventional b/pTa pre-TCR in thymocytes exceed-
ingly difficult (Groettrup et al., 1993).where DP cell development was induced in the absence
of TCR expression, such as in RAG2/2 mice injected The generation of DP thymocytes in g transgenic RAG-
12/2 mice is only approximately 1% as efficient as thewith MAbs specific for CD3e (Shinkai and Alt, 1994).
Instead, the data suggest that the smaller number of generation of DP thymocytes in b transgenic RAG-12/2
mice. The DP cells that are generated also exhibitedDP cells in TCRgSi RAG-12/2 transgenic mice is most
likely due to reduced differentiation of precursor cells distinct phenotypic characteristics, typical of DP cells
observed in other systems where DP cell generation isto DP thymocytes.
inefficient (Crompton et al., 1994; Fehling et al., 1995;
Kang et al., 1998). The low efficiency of DP cell genera-Discussion
tion induced by the g/pTa pre-TCR could be due to
quantitative differences in g/pTa function compared toIf asked why endogenous TCRg chains cannot support
development of DP thymocytes, most researchers in the the b/pTa pre-TCR. The fact that anti-Vg2 MAb stimula-
tion of the putative g/pTa receptor resulted in enhancedfield would probably suggest that it is because g chains
cannot pair with pTa chains. This possibility is refuted numbers of DP cells, which exhibit a phenotype charac-
teristic of the DP cells in normal mice, supports theby our results, which provide persuasive evidence that
TCRg, pTa, and CD3 can interact to generate an alterna- notion that the g/pTa receptor delivers weak signals
that can be enhanced by receptor cross-linking. Thetive pre-TCR capable of stimulating the development of
DP thymocytes. The observation that both the TCRg quantitative difference could arise if there are few g/pTa
receptors per cell, as might occur if the g chain associ-and -b chains can function with pTa indicates an unex-
pected degree of promiscuity in the specificity of pTa ates poorly with pTa. Alternatively, each g/pTa receptor
could elicit weaker signals than each b/pTa receptor,for its partner chain. The alternative pre-TCR stimulates
DP cell development substantially less well than the due to inefficient signal transducing capacity of the re-
ceptor. The possibility that the difference is due to theconventional pre-TCR. Significantly, in normal mice, the
capacity of the alternative pre-TCR to stimulate DP cell absence of a ligand for the g/pTa receptor should also
be considered. However, this possibility may be lessdevelopment is limited by the transcriptional repression
of g genes that normally accompanies DP cell develop- likely in light of evidence that b/pTa receptor function
may not require a ligand, since neither the Vb extracellu-ment. Therefore, although the g chain can pair with pTa
and induce differentiation towards the ab lineage, differ- lar domain (Krimpenfort et al., 1989) nor the extracellular
domain of pTa is absolutely required for efficient DPentiation is normally stalled at this point due to repres-
sion of g expression. Hence, this transcriptional regula- cell generation (Irving and Killeen, 1998).
Alternatively, signals transmitted by the TCRg/pTation further ensures preferential generation of sustained
A Pre-TCR Containing TCRg Chains
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pre-TCR might be qualitatively distinct from those elic- the observed selection against productive g and d genes
in ab lineage cells (Dudley et al., 1995; Kang et al., 1995;ited by the TCRb/pTa complex. For example, the g/pTa
receptor may induce differentiation of DP cells, without Livak et al., 1995) persuasively demonstrates that both
g and d genes can be expressed inputative ab-restrictedproviding a separate signal necessary for proliferation
that is supplied by the conventional pre-TCR. DN cells. Hence, it cannot be argued that g genes are
normally constitutively transcriptionally repressed inConsidering that the extracellular domain of TCRb is
not required for efficient DP cell generation and that the these cells (Ishida et al., 1990), thereby preventing DP
cell generation via the g/pTa pre-TCR. However, it isb chain (like the g chain) contains only a very small
cytoplasmic domain, the possibility arises that the rele- plausible that g/pTa function in putative ab-restricted
DN cells is blunted by g gene repression that occursvant difference(s) between the b and g chains with re-
spect to pre-TCR function lies in the transmembrane later, perhaps during theDN to DP transition. Thus, there
may be a requirement for sustained g/pTa signaling toregion. All four TCR chains, as well as pTa, contain a
charged lysine residue in the transmembrane region that mediate this differentiation event. We have made a simi-
lar proposal (Kang et al., 1998) in accounting for theis thought to mediate associations with negatively
charged residues in the transmembrane domains of CD3 capacity of the gdTCR to stimulate the generation of DP
cells (Iwashima et al., 1991; Kersh et al., 1995; Livak etsubunits. Interestingly, the transmembrane domain of
TCRb chain contains a second charged residue, glu- al., 1997). The gdTCR ranks between the b/pTa pre-TCR
and the g/pTa pre-TCR in its capacity to stimulate thistamic acid, that is lacking in the TCRCg1 chain. This
glutamic acid residue may form a charged pair with a transition. The superior activity of the gd receptor com-
pared to the g/pTa receptor in inducing DP cell develop-corresponding second charged residue (arginine) of the
pTa transmembrane domain, enhancing associations ment could be attributed to its greater abundance, a
longer half-life, or to its potential capacity to deliverbetween b and pTa. Alternatively, the glutamic acid resi-
due may mediate interactions with other signaling mole- stronger signals.
Alternatively, in the instructive model of gd/ab T cellcules.
While the transgenic g chain drives the production of lineage determination (Allison and Lanier, 1987; Dudley
et al., 1995; Livak et al., 1995; Kang and Raulet, 1997;appreciable numbers of DP cells, endogenously en-
coded g chains do so much less efficiently. This discrep- Kang et al., 1998), an uncommitted pTa-expressing DN
cell is capable of rearranging b, g, and d genes, andancy may be attributed to the fact that only a fraction
of progenitor cells in normal mice are expected to re- the developmental outcome is dictated by differential
receptor signaling. In this model, b/pTa receptors effi-arrange TCRg genes productively, but this explanation
cannot account for much of the difference. The results ciently induce DP cell generation and proliferation, and
gd TCRs mainly promote differentiation of gd cells. Theprovide evidence that the repression of g gene transcrip-
tion that normally occurs as progenitor cells differentiate TCRg chain can associate with the pTa chain, but sig-
nals from the pre-TCR would transcriptionally silenceinto DP cells is important in preventing the endogenous
g chains from promoting appreciable DP cell generation. the g gene expression, effectively limiting the generation
of DP thymocytes using this pathway. Thus, modifiedWe compared the original transgene with a longer (gSi)
transgene that is identical except that it contains addi- versions of both the instructive and stochastic models
of lineage commitment can account for the activity oftional downstream regulatory sequences. Both trans-
genes were expressed at similar levels in DN cells, but TCRg chain in concert with the pTa/CD3 complex.
It is now evident that four TCR complex isoforms canunlike the original transgene, expression of gSi was re-
pressed in DP cells. The endogenous g genes are also induce DP cell development with varying efficiencies:
the b/pTa pre-TCR (Groettrup et al., 1993; Fehling et al.,transcriptionally repressed in DP cells as well as in other
ab lineage cells (Garman et al., 1986; Ishida et al., 1990; 1995), the ab TCR (Buer et al., 1997), the gd TCR (Livak
et al., 1997; Passoni et al., 1997; Kang et al., 1998), andWilson et al., 1996). In gSi transgenic RAG2/2 mice only
very small numbers of DP cells were generated, similar the g/pTa pre-TCR. In addition to the inherently lower
capacities of the gd and g/pTa receptors to stimulateto the situation in TCRb2/2d2/2 mice. In both cases, the
strongly reduced numbers of DP thymocytes probably DP cell generation, transcriptional down-regulation of
the g and probably the d genes (Wilson et al., 1996)occurs because the down-regulation of the TCRg/pTa
pre-TCR complex prevents sustained generation of sig- limits DP cell generation via signals emanating from
these receptors. The DP cells that do arise as a resultnals necessary to allow significant differentiation of pre-
cursor cells into DP thymocytes. The transcriptional re- of the expression of g/pTa and gd receptors presumably
do not differentiate further, since these receptors maypression in DP cells of the gSi transgenic construct will
be described in detail elsewhere. not be capable of undergoing normal positive selection
events, in large part as a result of transcriptional silenc-At what point during T cell development does g gene
repression normally occur, and how do our results fit into ing of the receptor genes. While a detailed picture is
emerging of the activities of different receptor isoformsmodels of the gd/ab T cell fate decision? In a previously
proposed stochastic model of the gd/ab lineage deci- in T cell progenitors, an understanding is lacking of the
basic developmental mechanisms and precisely howsion, DN cells undergo a stochastic commitment to gd
or ab lineage, but both types of committed cells remain expression of the different receptor isoforms impact
these processes. Resolution of these issues will likelycapable of rearranging b, g, and d genes (Kang and
Raulet, 1997; Livak et al., 1997; Kang et al., 1998). In require methods to follow all of the descendants of sin-
gle early progenitor cells or the delineation of distinctiveone version of this model, pTa expression is restricted
to ab committed DN cells (Fehling et al., 1997; Mert- phenotypes for putative lineage committed early pro-
genitor cells.sching et al., 1997). As discussed in detail elsewhere,
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Experimental Procedures In brief, BrdU (0.9 mg) was injected i.p. into the mice at 8 hr intervals.
The thymocytes were isolated at 24 hr posttreatment and stained
with anti-CD252PE, anti-CD4-613, and anti-CD8-670 MAbs, fol-Mice
Generation of G8 TCRg transgenic mice (Kang et al., 1998) and lowed by fixation, permeablization, and staining with BrdU-FITC
(Becton Dickinson) MAb. Side- and forward-gated 105 labeled cellspTa2/2 mice (Fehling et al., 1995) have been described previously.
G8 TCRgSi transgene contains an additional 10 kb fragment (from were analyzed by four-color cytometry using EPICS V (Coulter).
a BALB/c genomic clone kindly provided by Dr. L. Hood, Seattle)
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